drugset / Trial / NCT01472432

DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes

NCT01472432

Phase 4 Completed 106 enrolled University of Campania Luigi Vanvitelli
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized versus placebo trial designed to evaluate the clinical and humoral effects of 4 months of vildagliptin on healing of chronic ulcers in type 2 diabetes.

Timeline

Start
2011-05
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Vildagliptin Other / unclassified 50 mg Oral

Indications